BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37168102)

  • 1. Microarray patch for HIV prevention and as a multipurpose prevention technology to prevent HIV and unplanned pregnancy: an assessment of potential acceptability, usability, and programmatic fit in Kenya.
    Gachigua SG; Karuga R; Ngunjiri A; Jarrahian C; Coffey PS; Kilbourne-Brook M; Otiso L
    Front Reprod Health; 2023; 5():1125159. PubMed ID: 37168102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring user and stakeholder perspectives from South Africa and Uganda to refine microarray patch development for HIV PrEP delivery and as a multipurpose prevention technology.
    Ismail A; Magni S; Katahoire A; Ayebare F; Siu G; Semitala F; Kyambadde P; Friedland B; Jarrahian C; Kilbourne-Brook M
    PLoS One; 2023; 18(8):e0290568. PubMed ID: 37651432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using a HIV prevention cascade for identifying missed opportunities in PrEP delivery in Kenya: results from a programmatic surveillance study.
    Were D; Musau A; Mutegi J; Ongwen P; Manguro G; Kamau M; Marwa T; Gwaro H; Mukui I; Plotkin M; Reed J
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25537. PubMed ID: 32602658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferences, educational messaging, and demand creation channels for multipurpose-prevention technologies (MPTs) among women in South Africa.
    Mataboge P; Mthimkhulu N; Kutywayo A; Martin CE; Mazibuko M; Kwatsha K; Makalela N; Briedenhann E; Butler V; Bothma R; Mullick S
    BMC Public Health; 2023 Oct; 23(1):2090. PubMed ID: 37880628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa.
    Rousseau E; Bekker LG; Julies RF; Celum C; Morton J; Johnson R; Baeten JM; O'Malley G
    BMC Health Serv Res; 2021 Aug; 21(1):888. PubMed ID: 34454505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased condom use among key populations using oral PrEP in Kenya: results from large scale programmatic surveillance.
    Manguro GO; Musau AM; Were DK; Tengah S; Wakhutu B; Reed J; Plotkin M; Luchters S; Gichangi P; Temmerman M
    BMC Public Health; 2022 Feb; 22(1):304. PubMed ID: 35164707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community perspectives on barriers and challenges to HIV pre-exposure prophylaxis access by men who have sex with men and female sex workers access in Nigeria.
    Emmanuel G; Folayan M; Undelikwe G; Ochonye B; Jayeoba T; Yusuf A; Aiwonodagbon B; Bilali C; Umoh P; Ojemeiri K; Kalaiwo A
    BMC Public Health; 2020 Jan; 20(1):69. PubMed ID: 31941469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the costs and perceived benefits of oral pre-exposure prophylaxis (PrEP) delivery in ten counties of Kenya: a costing and a contingent valuation study.
    Forsythe S; Kioko U; Mahiane G; Glaubius R; Musau A; Gichangi A; Reed J; Were D
    Front Reprod Health; 2024; 6():1278764. PubMed ID: 38463424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Policy considerations for scaling up access to HIV pre-exposure prophylaxis for adolescent girls and young women: Examples from Kenya, South Africa, and Uganda.
    Lane J; Brezak A; Patel P; Verani AR; Benech I; Katz A
    Int J Health Plann Manage; 2021 Sep; 36(5):1789-1808. PubMed ID: 34159630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making the Case for Joint Decision-Making in Future Multipurpose Prevention Technology (MPT) Choice: Qualitative Findings on MPT Attribute Preferences from the CUPID Study (MTN-045).
    Bhushan NL; Musara P; Hartmann M; Stoner MCD; Shah SR; Nabukeera J; Rukundo I; Mutero P; Lewis MA; Piper J; Shapley-Quinn MK; Etima J; Minnis AM
    J Int AIDS Soc; 2022 Oct; 25(10):e26024. PubMed ID: 36254362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MPrEP+ study protocol: a prospective cohort study assessing the feasibility and acceptability of an HIV pre-exposure prophylaxis (PrEP) strategy for male clients of female sex workers in Kisumu, Kenya.
    Mantell J; Franks J; Zerbe A; Lamb MR; Reed DM; Omollo D; Lahuerta M; Naitore D; El-Sadr WM; Agot K
    BMJ Open; 2022 Nov; 12(11):e064037. PubMed ID: 36332953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Awareness, Yet Low Uptake, of Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women Within Family Planning Clinics in Kenya.
    Sila J; Larsen AM; Kinuthia J; Owiti G; Abuna F; Kohler PK; John-Stewart G; Pintye J
    AIDS Patient Care STDS; 2020 Aug; 34(8):336-343. PubMed ID: 32757980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinic-Integrated Smartphone App (JomPrEP) to Improve Uptake of HIV Testing and Pre-exposure Prophylaxis Among Men Who Have Sex With Men in Malaysia: Mixed Methods Evaluation of Usability and Acceptability.
    Shrestha R; Altice FL; Khati A; Azwa I; Gautam K; Gupta S; Sullivan PS; Ni Z; Kamarulzaman A; Phiphatkunarnon P; Wickersham JA
    JMIR Mhealth Uhealth; 2023 Feb; 11():e44468. PubMed ID: 36795465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of end-user research to inform future multipurpose prevention technologies in sub-Saharan Africa: a scoping review.
    Bhushan NL; Ridgeway K; Luecke EH; Palanee-Phillips T; Montgomery ET; Minnis AM
    Front Reprod Health; 2023; 5():1156864. PubMed ID: 37325244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative characterizations of relationships among South African adolescent girls and young women and male partners: implications for engagement across HIV self-testing and pre-exposure prophylaxis prevention cascades.
    Holmes LE; Kaufman MR; Casella A; Mudavanhu M; Mutunga L; Polzer T; Bassett J; Van Rie A; Schwartz S
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25521. PubMed ID: 32603025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study.
    Tapsoba JD; Cover J; Obong'o C; Brady M; Cressey TR; Mori K; Okomo G; Kariithi E; Obanda R; Oluoch-Madiang D; Chen YQ; Drain P; Duerr A
    PLoS Med; 2022 Sep; 19(9):e1004097. PubMed ID: 36095005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
    Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
    Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unmet Need for Contraception Among Female Sex Workers Initiating Oral Pre-Exposure Prophylaxis for HIV Prevention During Kenya's National Scale-Up: Results From a Programmatic Surveillance Study.
    Kamau M; Musau A; Were D; Waruguru G; Kabue M; Mutegi J; Plotkin M; Reed J
    Front Glob Womens Health; 2021; 2():747784. PubMed ID: 35265940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giving voice to the end-user: input on multipurpose prevention technologies from the perspectives of young women in Kenya and South Africa.
    Minnis AM; Krogstad E; Shapley-Quinn MK; Agot K; Ahmed K; Danielle Wagner L; van der Straten A;
    Sex Reprod Health Matters; 2021 Dec; 29(1):1927477. PubMed ID: 34224341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key programmatic and policy considerations for introducing multipurpose prevention (MPT) methods: reflections from healthcare providers and key stakeholders in South Africa.
    Kutywayo A; Mataboge P; Mthimkhulu N; Martin CE; Muhwava LS; Mazibuko M; Makalela N; Kwatsha K; Butler V; Mullick S
    Front Reprod Health; 2024; 6():1249750. PubMed ID: 38444890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.